THE EFFECTS OF ASCORBIC-ACID AND OXIRACETAM ON SCOPOLAMINE-INDUCED AMNESIA IN A HABITUATION TEST IN AGED MICE

被引:27
作者
DEANGELIS, L
FURLAN, C
机构
[1] Institute of Pharmacology, University of Trieste, 34127 Trieste
[2] 34143 Trieste
关键词
D O I
10.1006/nlme.1995.1050
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 [法学]; 0303 [社会学]; 030303 [人类学]; 04 [教育学]; 0402 [心理学];
摘要
The effects of a nootropic drug, oxiracetam (50-100-200 mg/kg ip), and a potent antioxidant agent, ascorbic acid (62.5-125-250 mg/kg ip), administered alone or in combination, were investigated an scopolamine-induced amnesia in a mouse habituation test. The light- dark aversion test was selected and was carried out in aged mice. Habituation to the test box occurred over a 3-day period, control mice showing a significant between-day increase in the time spent in the dark box, but not in the number of transitions. On Day 4, following post-trial administration over a 3-day period of oxiracetam (50-100 and 200 mg/kg ip) or ascorbic acid (62.5-125 and 250 mg/kg ip), a significant between-day increase in the time spent in the black area, but not in the number of transitions, was found. The combination of oxiracetam (100 mg/kg ip) with ascorbic acid (125 mg/kg ip) produced a similar pattern of results. The acute administration of scopolamine (0.25 mg/kg ip) to mice treated over a 3-day period with vehicle disrupted the habituation response. In mice that had received the 3-day treatment with oxiracetam or ascorbic acid or its combination, scopolamine failed to alter significantly the learning pattern. In conclusion, these data demonstrate that ascorbic acid, alone or in combination with oxiracetam, may prevent experimentally induced amnesia in aged mice. (C) 1995 Academic Press, Inc.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 24 条
[1]
BELZUNG C, 1988, PSYCHOPHARMACOLOGY, V95, P516
[2]
EXPLORATION OF MICE IN A BLACK AND WHITE TEST BOX - VALIDATION AS A MODEL OF ANXIETY [J].
COSTALL, B ;
JONES, BJ ;
KELLY, ME ;
NAYLOR, RJ ;
TOMKINS, DM .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 32 (03) :777-785
[3]
DEANGELIS L, 1987, METHOD FIND EXP CLIN, V9, P279
[4]
DEANGELIS L, 1991, CURR THER RES CLIN E, V49, P267
[5]
COMPARATIVE EFFECTS OF VALPROATE, ANXIOLYTIC, OR ANXIOGENIC DRUGS ON THE LIGHT DARK AVERSION TEST [J].
DEANGELIS, L .
DRUG DEVELOPMENT RESEARCH, 1992, 25 (04) :331-338
[6]
THE NOOTROPIC DRUGS PIRACETAM AND OXIRACETAM DO NOT REDUCE ANXIETY IN MICE DURING ELEVATED-X-MAZE TESTING [J].
DEANGELIS, L .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 52 (02) :230-237
[7]
NEUROCHEMICAL AND BEHAVIORAL-CHANGES INDUCED BY ASCORBIC-ACID AND D-AMPHETAMINE IN THE RAT [J].
DESOLE, MS ;
ANANIA, V ;
ESPOSITO, G ;
CARBONI, F ;
SENINI, A ;
MIELE, E .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1987, 19 (06) :441-450
[8]
LONG-TERM SUPPRESSION OF THE DEVELOPMENT OF COMPLEMENTARY MEMORY STORAGE SITES IN MICE - FUNCTIONAL INTERDEPENDENCE OF ACETYLCHOLINE AND DOPAMINE [J].
FLEXNER, JB ;
CHURCH, AC ;
FLEXNER, LB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (02) :617-619
[9]
A DECREASE IN BRAIN CATECHOLAMINES PREVENTS OXIRACETAM ANTAGONISM OF THE EFFECTS OF SCOPOLAMINE ON MEMORY AND BRAIN ACETYLCHOLINE [J].
GIOVANNINI, MG ;
SPIGNOLI, G ;
CARLA, V ;
PEPEU, G .
PHARMACOLOGICAL RESEARCH, 1991, 24 (04) :395-405
[10]
HEIKKILA RE, 1981, RES COMMUN CHEM PATH, V34, P409